AMERSHAM TSH CONTROL SERA— 510(k) K902760

Name: FDA 510(k) clearance K902760
Creator: U.S. Food and Drug Administration
Published: 1990-07-27

Substantially Equivalent

Amersham Corp.

FDA 510(k) clearance K902760 for AMERSHAM TSH CONTROL SERA, Substantially Equivalent on 1990-07-27. Applicant: Amersham Corp.. Device class: 1.

Clearance details

Applicant: Amersham Corp.
Product code: Code JJX
Device class: Class 1
Regulation: 21 CFR 862.1660
Advisory panel: Clinical Chemistry
Date received: 1990-06-25
Decision date: 1990-07-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Arlington Heights, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JJX

view all

K170678 — Beta-CrossLaps CalCheck 52017-04-04
K162173 — Elecsys CYFRA 21-1 CalCheck 52017-01-12
K162514 — Multichem A1c2016-10-26
K161874 — Audit MicroControls Linearity DROP LQ Blood Glucose2016-08-10
K161522 — LIAISON EBV IgM Serum Control Set2016-06-30

More clearances from Amersham Corp.

view all

K914135 — AMERLITE(TM) PROLACTIN-30 ASSAY, LAN.0086/20861992-02-18
K912733 — AMERLEX-M SPECIFIC ESTROL(UNCONJUGATED) RIA KIT1991-07-22
K912766 — AMERLITE CK-MB ASSAY1991-07-17
K904666 — AMERLITE TSH-60 ASSAY PRODUCT CODE: LAN. 0008/20081990-11-02
K901832 — GADOLINIUM-153 BONE DENSITOMETER SOURCES GDC.104151990-07-09

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.